Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of The PediQUEST Response to Pain Of Children With Neurologic Disability (PQ-ResPOND) Intervention: a Pilot Randomized Controlled Trial (RCT)

NCT06075797 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT06075797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06075797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of The PediQUEST Response to Pain Of Children With Neurologic Disability (PQ-ResPOND) Intervention: a Pilot Randomized Controlled Trial (RCT)
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
May 8, 2024
Completion date
July 31, 2025
Enrollment
54 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral palsy infantile, disabilities multiple, pain